{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:09:23Z","timestamp":1777363763402,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/bf02938409","type":"journal-article","created":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T22:43:13Z","timestamp":1219099393000},"page":"198-204","source":"Crossref","is-referenced-by-count":11,"title":["Nutritional therapies in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"9","author":[{"given":"Marian L.","family":"Evatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02938409_CR1","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM:Diagnosis and treatment of Parkinson disease: molecules to medicine.J Clin Invest 2006, 116:1744\u20131754.","journal-title":"J Clin Invest"},{"issue":"Suppl 11","key":"BF02938409_CR2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/mds.20457","volume":"20","author":"CW Olanow","year":"2005","unstructured":"Olanow CW, Jankovic J:Neuroprotective therapy in Parkinson\u2019s disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.Mov Disord 2005, 20(Suppl 11):S3-S10.","journal-title":"Mov Disord"},{"key":"BF02938409_CR3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","volume":"64","author":"TB VanItallie","year":"2005","unstructured":"VanItallie TB, Nonas C, Di Rocco A et al.:Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.Neurology 2005, 64:728\u2013730.","journal-title":"Neurology"},{"key":"BF02938409_CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8257(200001)15:1<164::AID-MDS1028>3.0.CO;2-E","volume":"15","author":"H Apaydin","year":"2000","unstructured":"Apaydin H, Ertan S, Ozekmekci S:Broad bean (Vicia faba)\u2014a natural source of L-dopa\u2014prolongs \u201con\u201d periods in patients with Parkinson\u2019s disease who have \u201con-off\u201d fluctuations.Mov Disord 2000, 15:164\u2013166.","journal-title":"Mov Disord"},{"key":"BF02938409_CR5","first-page":"681","volume":"60","author":"JM Rabey","year":"1993","unstructured":"Rabey JM, Vered Y, Shabtai H et al.:Broad bean (Vicia faba) consumption and Parkinson\u2019s disease.Adv Neurol 1993, 60:681\u2013684.","journal-title":"Adv Neurol"},{"key":"BF02938409_CR6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jnnp.55.8.725","volume":"55","author":"JM Rabey","year":"1992","unstructured":"Rabey JM, Vered Y, Shabtai H, et al.:Improvement of parkinsonian features correlates with high plasma levodopa values after broad bean (Vicia faba) consumption.J Neurol Neurosurg Psychiatry 1992, 55:725\u2013727.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02938409_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20380","volume":"20","author":"SS Ladha","year":"2005","unstructured":"Ladha SS, Walker R, Shill HA:Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.Mov Disord 2005, 20:630\u2013631.","journal-title":"Mov Disord"},{"key":"BF02938409_CR8","first-page":"565","volume":"80","author":"BV Manyam","year":"1999","unstructured":"Manyam BV, Sanchez-Ramos JR:Traditional and complementary therapies in Parkinson\u2019s disease.Adv Neurol 1999, 80:565\u2013574.","journal-title":"Adv Neurol"},{"key":"BF02938409_CR9","doi-asserted-by":"crossref","unstructured":"An alternative medicine treatment for Parkinson\u2019s disease: results of a multicenter clinical trial. HP-200 in Parkinson\u2019s Disease Study Group.J Altern Complement Med 1995, 1:249\u2013255.","DOI":"10.1089\/acm.1995.1.249"},{"key":"BF02938409_CR10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/jnnp.2003.028761","volume":"75","author":"R Katzenschlager","year":"2004","unstructured":"Katzenschlager R, Evans A, Manson A, et al.:Mucuna pruriens in Parkinson\u2019s disease: a double blind clinical and pharmacological study.J Neurol Neurosurg Psychiatry 2004, 75:1672\u20131677.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02938409_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM197501232920404","volume":"292","author":"I Mena","year":"1975","unstructured":"Mena I, Cotzias GC:Protein intake and treatment of Parkinson\u2019s disease with levodopa.N Engl J Med 1975, 292:181\u2013184.","journal-title":"N Engl J Med"},{"key":"BF02938409_CR12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archneur.1987.00520220012007","volume":"44","author":"JH Pincus","year":"1987","unstructured":"Pincus JH, Barry KM:Plasma levels of amino acids correlate with motor fluctuations in parkinsonism.Arch Neurol 1987, 44:1006\u20131009.","journal-title":"Arch Neurol"},{"key":"BF02938409_CR13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archneur.1987.00520150026014","volume":"44","author":"JH Pincus","year":"1987","unstructured":"Pincus JH, Barry K:Influence of dietary protein on motor fluctuations in Parkinson\u2019s disease.Arch Neurol 1987, 44:270\u2013272.","journal-title":"Arch Neurol"},{"key":"BF02938409_CR14","first-page":"133","volume":"60","author":"JH Pincus","year":"1987","unstructured":"Pincus JH, Barry KM:Dietary method for reducing fluctuations in Parkinson\u2019s disease.Yale J Biol Med 1987, 60:133\u2013137.","journal-title":"Yale J Biol Med"},{"key":"BF02938409_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.38.3.481","volume":"38","author":"JH Pincus","year":"1988","unstructured":"Pincus JH, Barry K:Protein redistribution diet restores motor function in patients with dopa-resistant \u201coff\u201d periods.Neurology 1988, 38:481\u2013483.","journal-title":"Neurology"},{"key":"BF02938409_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archneur.1992.00530260049018","volume":"49","author":"PJ Karstaedt","year":"1992","unstructured":"Karstaedt PJ, Pincus JH:Protein redistribution diet remains effective in patients with fluctuating parkinsonism.Arch Neurol 1992, 49:149\u2013151.","journal-title":"Arch Neurol"},{"key":"BF02938409_CR17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/ajcn\/55.3.701","volume":"55","author":"S Pare","year":"1992","unstructured":"Pare S, Barr SI, Ross SE:Effect of daytime protein restriction on nutrient intakes of free-living Parkinson\u2019s disease patients.Am J Clin Nutr 1992, 55:701\u2013707.","journal-title":"Am J Clin Nutr"},{"key":"BF02938409_CR18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1212\/WNL.41.8.1295","volume":"41","author":"EM Berry","year":"1991","unstructured":"Berry EM, Growdon JH, Wurtman JJ, et al.:A balanced carbohydrate: protein diet in the management of Parkinson\u2019s disease.Neurology 1991, 41:1295\u20131297.","journal-title":"Neurology"},{"key":"BF02938409_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002826-198712000-00004","volume":"10","author":"A Baruzzi","year":"1987","unstructured":"Baruzzi A, Contin M, Riva R, et al.:Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients.Clin Neuropharmacol 1987, 10:527\u2013537.","journal-title":"Clin Neuropharmacol"},{"key":"BF02938409_CR20","first-page":"51","volume":"37","author":"DK Reilly","year":"1983","unstructured":"Reilly DK, Hershey L, Rivera-Calimlim L, Shoulson I:On-off effects in Parkinson\u2019s disease: a controlled investigation of ascorbic acid therapy.Adv Neurol 1983, 37:51\u201360.","journal-title":"Adv Neurol"},{"key":"BF02938409_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.30198","volume":"137","author":"EK Tan","year":"2005","unstructured":"Tan EK, Cheah SY, Fook-Chong S, et al.:Functional COMT variant predicts response to high dose pyridoxine in Parkinson\u2019s disease.Am J Med Genet B Neuropsychiatr Genet 2005, 137:1\u20134.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BF02938409_CR22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.46.4.1051","volume":"46","author":"R Djaldetti","year":"1996","unstructured":"Djaldetti R, Baron J, Ziv I, Melamed E:Gastric emptying in Parkinson\u2019s disease: patients with and without response fluctuations.Neurology 1996, 46:1051\u20131054.","journal-title":"Neurology"},{"key":"BF02938409_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","volume":"2","author":"RF Pfeiffer","year":"2003","unstructured":"Pfeiffer RF:Gastrointestinal dysfunction in Parkinson\u2019s disease.Lancet Neurol 2003, 2:107\u2013116.","journal-title":"Lancet Neurol"},{"key":"BF02938409_CR24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-277X.2005.00652.x","volume":"18","author":"K Gustafsson","year":"2005","unstructured":"Gustafsson K, Ekblad J, Sidenvall B:Older women and dietary advice: occurrence, comprehension and compliance.J Hum Nutr Diet 2005, 18:453\u2013460.","journal-title":"J Hum Nutr Diet"},{"issue":"Suppl 7","key":"BF02938409_CR25","first-page":"vII18","volume":"251","author":"A Ueki","year":"2004","unstructured":"Ueki A, Otsuka M:Life style risks of Parkinson\u2019s disease: association between decreased water intake and constipation.J Neurol 2004, 251 (Suppl 7):vII18-vII23.","journal-title":"J Neurol"},{"key":"BF02938409_CR26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01720610-200611000-00005","volume":"19","author":"J Drost","year":"2006","unstructured":"Of major importance Drost J, Harris LA:Diagnosis and management of chronic constipation.JAAPA 2006, 19:24\u201329. A review outlining a comprehensive approach for chronic constipation management.","journal-title":"JAAPA"},{"key":"BF02938409_CR27","doi-asserted-by":"crossref","first-page":"2739S","DOI":"10.1093\/jn\/135.11.2739S","volume":"135","author":"MF Holick","year":"2005","unstructured":"Of importance Holick MF:The vitamin D epidemic and its health consequences.J Nutr 2005, 135:2739S-2748S. A good review on vitamin D.","journal-title":"J Nutr"},{"key":"BF02938409_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000091825","volume":"52","author":"B Lorefat","year":"2006","unstructured":"Lorefat B, Ganowiak W, Wissing U, et al.:Food habits and intake of nutrients in elderly patients with Parkinson\u2019s disease.Gerontology 2006, 52:160\u2013168.","journal-title":"Gerontology"},{"key":"BF02938409_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/mds.20837","volume":"21","author":"EY Uc","year":"2006","unstructured":"Uc EY, Struck LK, Rodnitzky RL, et al.:Predictors of weight loss in Parkinson\u2019s disease.Mov Disord 2006, 21:930\u2013936.","journal-title":"Mov Disord"},{"key":"BF02938409_CR30","first-page":"255","volume":"10","author":"AG Mamhidir","year":"2006","unstructured":"Mamhidir AG, Ljunggren G, Kihlgren M, et al.:Underweight, weight loss and related risk factors among older adults in sheltered housing\u2014a Swedish follow-up study.J Nutr Health Aging 2006, 10:255\u2013262.","journal-title":"J Nutr Health Aging"},{"key":"BF02938409_CR31","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1365-2702.2005.01454.x","volume":"15","author":"B Lorefalt","year":"2006","unstructured":"Lorefalt B, Granerus AK, Unosson M:Avoidance of solid food in weight losing older patients with Parkinson\u2019s disease.J Clin Nurs 2006, 15:1404\u20131412.","journal-title":"J Clin Nurs"},{"issue":"Suppl 7","key":"BF02938409_CR32","first-page":"vii38","volume":"253","author":"K Kashihara","year":"2006","unstructured":"Of major importance Kashihara K:Weight loss in Parkinson\u2019s disease.J Neurol 2006, 253(Suppl 7):vii38-vii41. Recent review of issues relating to weight loss in PD.","journal-title":"J Neurol"},{"key":"BF02938409_CR33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/mds.21068","volume":"21","author":"CG Bachmann","year":"2006","unstructured":"Bachmann CG, Trenkwalder C:Body weight in patients with Parkinson\u2019s disease.Mov Disord 2006, 21:1824\u20131830.","journal-title":"Mov Disord"},{"key":"BF02938409_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2004.00307.x","volume":"110","author":"B Lorefalt","year":"2004","unstructured":"Lorefalt B, Ganowiak W, Palhagen S, et al.:Factors of importance for weight loss in elderly patients with Parkinson\u2019s disease Acta Neurol Scand 2004, 110:180\u2013187.","journal-title":"Acta Neurol Scand"},{"key":"BF02938409_CR35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jnnp.2003.033373","volume":"76","author":"H Sienkiewicz-Jarosz","year":"2005","unstructured":"Sienkiewicz-Jarosz H, Scinska A, Kuran W, et al.:Taste responses in patients with Parkinson\u2019s disease.J Neurol Neurosurg Psychiatry 2005, 76:40\u201346.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02938409_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00415-005-0916-7","volume":"253","author":"M D\u2019Amelio","year":"2006","unstructured":"D\u2019Amelio M, Ragonese P, Morgante L, et al.:Long-term survival of Parkinson\u2019s disease: a population-based study.J Neurol 2006, 253:33\u201337.","journal-title":"J Neurol"},{"key":"BF02938409_CR37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.47.3.636","volume":"47","author":"W Hellenbrand","year":"1996","unstructured":"Hellenbrand W, Seidler A, Boeing H, et al.:Diet and Parkinson\u2019s disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study.Neurology 1996, 47:636\u2013643.","journal-title":"Neurology"},{"key":"BF02938409_CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-0404.2000.101002079.x","volume":"101","author":"WG Ondo","year":"2000","unstructured":"Ondo WG, Ben-Aire L, Jankovic J, et al.:Weight gain following unilateral pallidotomy in Parkinson\u2019s disease Acta Neurol Scand 2000, 101:79\u201384.","journal-title":"Acta Neurol Scand"},{"key":"BF02938409_CR39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","volume":"21","author":"MJ Nirenberg","year":"2006","unstructured":"Nirenberg MJ, Waters C:Compulsive eating and weight gain related to dopamine agonist use.Mov Disord 2006, 21:524\u2013529.","journal-title":"Mov Disord"},{"key":"BF02938409_CR40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/mds.20902","volume":"21","author":"SC Wolfrath","year":"2006","unstructured":"Wolfrath SC, Borenstein AR, Schwartz S, et al.:Use of nutritional supplements in parkinson\u2019s disease patients.Mov Disord 2006, 21:1098\u20131101.","journal-title":"Mov Disord"},{"key":"BF02938409_CR41","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/WNL.57.5.790","volume":"57","author":"PR Rajendran","year":"2001","unstructured":"Rajendran PR, Thompson RE, Reich SG:The use of alternative therapies by patients with Parkinson\u2019s disease.Neurology 2001, 57:790\u2013794.","journal-title":"Neurology"},{"key":"BF02938409_CR42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/01.wnl.0000206363.57955.1b","volume":"66","author":"O Suchowersky","year":"2006","unstructured":"Of major importance Suchowersky O, Gronseth G, Perlmutter J, et al.:Practice parameter: neuroprotective strategies and alternative therapies for Parkinson\u2019s disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology 2006, 66:976\u2013982. The American Academy of Neurology practice parameter on neuroprotective and alternative therapies for PD.","journal-title":"Neurology"},{"key":"BF02938409_CR43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1079\/NRR2005108","volume":"18","author":"L Ishihara","year":"2005","unstructured":"Of major importance Ishihara L, Brayne C:A systematic review of nutritional risk factors of Parkinson\u2019s disease.Nutr Res Rev 2005, 18:259\u2013282. A comprehensive meta-analysis and review of studies on nutritional risk factors for PD.","journal-title":"Nutr Res Rev"},{"key":"BF02938409_CR44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(05)70097-1","volume":"4","author":"M Etminan","year":"2005","unstructured":"Etminan M, Gill SS, Samii A:Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson\u2019s disease: a meta-analysis.Lancet Neurol 2005, 4:362\u2013365.","journal-title":"Lancet Neurol"},{"key":"BF02938409_CR45","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.46.5.1270","volume":"46","author":"DM Morens","year":"1996","unstructured":"Morens DM, Grandinetti A, Waslien CI, et al.:Case-control study of idiopathic Parkinson\u2019s disease and dietary vitamin E intake.Neurology 1996, 46:1270\u20131274.","journal-title":"Neurology"},{"key":"BF02938409_CR46","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/archneur.1989.00520460028009","volume":"46","author":"DATATOP","year":"1989","unstructured":"DATATOP:a multicenter controlled clinical trial in early Parkinson\u2019s disease. Parkinson Study Group.Arch Neurol 1989, 46:1052\u20131060.","journal-title":"Arch Neurol"},{"key":"BF02938409_CR47","doi-asserted-by":"crossref","first-page":"380S","DOI":"10.1093\/ajcn\/53.1.380S","volume":"53","author":"S Fahn","year":"1991","unstructured":"Fahn S:An open trial of high-dosage antioxidants in early Parkinson\u2019s disease.Am J Clin Nutr 1991, 53:380S-382S.","journal-title":"Am J Clin Nutr"},{"issue":"Suppl","key":"BF02938409_CR48","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/ana.410320722","volume":"32","author":"S Fahn","year":"1992","unstructured":"Fahn S:A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson\u2019s disease.Ann Neurol 1992, 32(Suppl):S128-S132.","journal-title":"Ann Neurol"},{"key":"BF02938409_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","volume":"142","author":"ER Miller","year":"2005","unstructured":"Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al.:Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.Ann Intern Med 2005, 142:37\u201346.","journal-title":"Ann Intern Med"},{"key":"BF02938409_CR50","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"CW Shults","year":"2002","unstructured":"Shults CW, Oakes D, Kieburtz K, et al.:Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.Arch Neurol 2002, 59:1541\u20131550.","journal-title":"Arch Neurol"},{"key":"BF02938409_CR51","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000219815.83681.f7","volume":"66","author":"RB Postuma","year":"2006","unstructured":"Postuma RB, Espay AJ, Zadikoff C, et al.:Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.Neurology 2006, 66:1941\u20131943.","journal-title":"Neurology"},{"key":"BF02938409_CR52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.WNF.0000236763.16032.60","volume":"29","author":"S Hassin-Baer","year":"2006","unstructured":"Hassin-Baer S, Cohen O, Vakil E, et al.:Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.Clin Neuropharmacol 2006, 29:305\u2013311.","journal-title":"Clin Neuropharmacol"},{"key":"BF02938409_CR53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2006.05.040","volume":"248","author":"Z Todorovic","year":"2006","unstructured":"Todorovic Z, Dzoljic E, Novakovic I, et al.:Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson\u2019s disease, with and without levodopa therapy.J Neurol Sci 2006, 248:56\u201361.","journal-title":"J Neurol Sci"},{"key":"BF02938409_CR54","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.amjmed.2005.01.052","volume":"118","author":"Y Sato","year":"2005","unstructured":"Sato Y, Iwamoto J, Kanoko T, Satoh K:Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson\u2019s disease.Am J Med 2005, 118:1250\u20131255.","journal-title":"Am J Med"},{"key":"BF02938409_CR55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2188\/jea.14.143","volume":"14","author":"Y Nakayama","year":"2004","unstructured":"Nakayama Y, Washio M, Mori M:Oral health conditions in patients with Parkinson\u2019s disease.J Epidemiol 2004, 14:143\u2013150.","journal-title":"J Epidemiol"},{"key":"BF02938409_CR56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00415-006-0068-4","volume":"253","author":"J Schwarz","year":"2006","unstructured":"Schwarz J, Heimhilger E, Storch A:Increased periodontal pathology in Parkinson\u2019s disease.J Neurol 2006, 253:608\u2013611.","journal-title":"J Neurol"},{"key":"BF02938409_CR57","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yrtph.2006.05.006","volume":"45","author":"JN Hathcock","year":"2006","unstructured":"Hathcock JN, Shao A:Risk assessment for coenzyme Q10 (ubiquinone).Regul Toxicol Pharmacol 2006, 45:282\u2013288.","journal-title":"Regul Toxicol Pharmacol"},{"key":"BF02938409_CR58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00063110-200504000-00007","volume":"12","author":"P Lheureux","year":"2005","unstructured":"Lheureux P, Penaloza A, Gris M:Pyridoxine in clinical toxicology: a review.Eur J Emerg Med 2005, 12:78\u201385.","journal-title":"Eur J Emerg Med"},{"key":"BF02938409_CR59","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1532-5415.2001.4911248.x","volume":"49","author":"CM Callahan","year":"2001","unstructured":"Callahan CM, Buchanan NN,, Stump TE:Healthcare costs associated with percutaneous endoscopic gastrotomy among older adults in a defined community.J Am Geriatr Soc 2001, 49:1525\u20131529.","journal-title":"J Am Geriatr Soc"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02938409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02938409\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02938409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T18:58:38Z","timestamp":1558551518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02938409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BF02938409"],"URL":"https:\/\/doi.org\/10.1007\/bf02938409","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}